BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20304055)

  • 21. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
    Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
    Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels.
    Anderson PH; Lee AM; Anderson SM; Sawyer RK; O'Loughlin PD; Morris HA
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):288-92. PubMed ID: 20236618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing "betel nut" (Areca catechu) and vitamin D status.
    Ogunkolade WB; Boucher BJ; Bustin SA; Burrin JM; Noonan K; Mannan N; Hitman GA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2612-7. PubMed ID: 16670168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model.
    Anderson PH; Sawyer RK; Moore AJ; May BK; O'Loughlin PD; Morris HA
    J Bone Miner Res; 2008 Nov; 23(11):1789-97. PubMed ID: 18597628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections.
    Mee AP; Hoyland JA; Braidman IP; Freemont AJ; Davies M; Mawer EB
    Bone; 1996 Apr; 18(4):295-9. PubMed ID: 8726384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of the vitamin D endocrine system in mammary gland and breast cancer.
    Welsh J
    Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis.
    D'Amelio P; Grimaldi A; Pescarmona GP; Tamone C; Roato I; Isaia G
    FASEB J; 2005 Mar; 19(3):410-2. PubMed ID: 15611151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 1α,25-(OH)2D3 on the formation and activity of osteoclasts in RAW264.7 cells.
    Gu J; Tong XS; Chen GH; Wang D; Chen Y; Yuan Y; Liu XZ; Bian JC; Liu ZP
    J Steroid Biochem Mol Biol; 2015 Aug; 152():25-33. PubMed ID: 25864627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ascorbic acid in the osteoclast formation: induction of osteoclast differentiation factor with formation of the extracellular collagen matrix.
    Otsuka E; Kato Y; Hirose S; Hagiwara H
    Endocrinology; 2000 Aug; 141(8):3006-11. PubMed ID: 10919289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo.
    Takahashi N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.
    Reinke DC; Starczak Y; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2018 Mar; 177():96-102. PubMed ID: 28765041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
    Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
    Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
    Hiruma Y; Hirai T; Tsuda E
    Biochem Biophys Res Commun; 2011 Jun; 409(3):424-9. PubMed ID: 21586272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
    Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
    Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M; Sato N
    Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
    Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
    Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of the osteoclastogenic potential of human osteoblastic and fibroblastic conditioned media.
    Costa-Rodrigues J; Teixeira CA; Sampaio P; Fernandes MH
    J Cell Biochem; 2010 Jan; 109(1):205-16. PubMed ID: 19911374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.